| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | 5G3P5OK11S |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C20H26N2O10S3 |
| Molecular Weight | 550.63 |
| AlogP | 3.16 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 81.28 |
| Molecular species | None |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 25.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | 1-phosphatidylinositol 3-phosphate 5-kinase inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298111 |
| FDA SRS | 5G3P5OK11S |
CONTENTS